On Fishing Expeditions, Laws of Fishing, and Good Fishermen…  by Narula, Jagat et al.
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nhe genesis of good research is based on
critical observations, but the way these ob-
servations come about seems to generate a
social-status hierarchy in the medical re-
earch community. Traditionally, successful re-
earch is viewed as a well deserved fruit of a neat
priori hypothesis, great toil, meticulous experi-
ents, and a juggernaut of logical reasoning. Ser-
ndipitous discovery, a previously unknown find-
ng that an investigator chances upon while
esting a primary hypothesis, occupies a slightly
esser standing in this hierarchy. However, since
here have been numerous examples of such suc-
ess and since the investigator deserves credit for
eeping his eyes open to the unexpected finding,
his kind of research is also often lauded. On the
ther hand, a fishing expedition, which explores
ome possible relation between several variables
hile often hoping wildly that something inter-
sting would show up, is considered to be of a di-
inished pedigree. Scientists in general, and grant
unding agencies as well as journal editors in par-
icular, have viewed it with disdain, even though
uch findings may help move the field forward.
While we, as editors, are also commonly prey
o this line of thinking, we often encourage our-
elves to be open to such studies if the data are
eally intriguing. One could also argue that re-
earch in general is quite unpredictable, and a
shing expedition, like many things in life, may
ot necessarily be a bad thing; such efforts may
ay off if something interesting is captured and
he ability to handle enormous amounts of data
rom the *Division of Cardiology, University of California Irvine, Irvine,
alifornia; †Cardiovascular Imaging Institute, Department of Cardiol-
gy, The Methodist DeBakey Heart and Vascular Center, Houston,o
exas; and the ‡Division of Cardiology, VA Medical Center and
niversity of Minnesota, Minneapolis, Minnesota.ight make such explorations even more useful.
his has already happened in genomics and pro-
eomics and is being increasingly seen in metabo-
omics. Indeed, the ever expanding computing
ower provides insights that could not be possible
ith traditional methods of fishing—a la the re-
nactment of the differences between gill-net fish-
ng versus traditional hook, line, and sinker meth-
ds. We will be seeing more fishing expeditions
n future medical research, and journals, despite
ome damage to their perceived prestige, will even-
ually be more open to publishing such studies.
Of course, such forays need an extreme amount
f caution. Fishing expeditions exponentially in-
rease the likelihood of false-positive and nonrepli-
able results and introduce bias. This should just
ake us increase the scientific protection to ensure
alidity of data rather than discourage its use alto-
ether. There are many ways to be conservative
bout outcomes in fishing expeditions including
obust statistical methodology to limit the number
f catches that can be considered “keepers” (1).
he greater the number of relationships tested,
he more conservative we have to be in order to
reserve the validity of observations. As good
shermen know, too much technology or too
any lines can often snag a lot of junk. The
ause and effect relationships of such findings,
ven though optimistically espoused by their au-
hors, are nearly always unclear. A large number
f associations will be red herrings and will en-
ender unfruitful investigations with loss of time
nd wasted resources. Finally, such data will be
onsidered nondefinitive, and will have to pass
he scrutiny of more rigorous hypothesis-based
xperimentation. The natural ferment of science is
eeded to finally determine if the results were real
r random.
i
e
c
t
e
g
t
a
a
s
I
m
b
T
g
m
t
m
i
t
c
b
d
w
g
s
d
fi
[
u
t
u
d
b
s
p
a
t
s
a
d
e
o
a
t
fi
e
o
p
s
i
1
m
d
i
i
1
d
e
t
p
g
m
f
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 3 , N O . 1 0 , 2 0 1 0
O C T O B E R 2 0 1 0 : 1 0 8 6 – 8
Narula et al.
Editor’s Page
1087The report by Eleid et al. (2) in this issue of
JACC might be an example of such a preliminary
xploration. This study characterizes the serial
hanges in left ventricular (LV) function for
ransplanted hearts, wherein the transplant recipi-
nts demonstrated an improvement in global lon-
itudinal strain within the first 3 months after
ransplantation. This functional improvement was
ssociated with reduced combined risk of death
nd hospitalization compared with those who
howed persistent strain abnormalities (Fig. 1).
nterestingly, patients with abnormalities in LV
echanics exceeded the number of patients with
iopsy-proven findings of acute cellular rejection.
his is consistent with previous data where the
lobal estimate of myocardial damage detected by
yocardial uptake of radiolabeled monoclonal an-
imyosin antibodies exceeded that seen in endo-
yocardial biopsy specimens (3,4) (Fig. 2). Dur-
ng the first few months after heart
ransplantation, patients invariably showed myo-
ardial uptake of monoclonal antimyosin anti-
ody, revealing the presence of active myocardial
amage. A gradual decrease in myocardial uptake
as later observed that was paralleled by a pro-
ressive reduction in the number of rejection epi-
odes in biopsy; this was considered to represent
evelopment of tolerance to the graft. Within the
rst 3 months (as also reported by Eleid et al.
2]), a substantial decrease in antimyosin antibody
ptake was observed in most patients; this resolu-
ion of radiotracer uptake was associated with an
neventful course, and less need for maintenance-
ose steroids and the number of endomyocardial
iopsies. On the other hand, a handful of patients
howing persistence of uptake or an increasing
attern of antimyosin antibody uptake predicted
n increased number of cellular and vascular rejec-
ion episodes, likelihood of complications, neces-
ity for retransplantation, and increased need for
dditional immunosuppressive agents and depen-
ence on steroids (3) (Fig. 2). This novel conflu-
nce of observations highlights the phenomenon
f retrodiction where older data are paralleled by
nother imaging modality achievable more easily;
he advantage indeed being that retrodiction con-
rms that the current expedition should be free of
xperimental bias. Although a logical result was
bserved in the study by Eleid et al. (2) and therimary hypothesis was vindicated in this retro-
pective evaluation, they further explored the clin-
cal determinants of persistent LV dysfunction at
-year after cardiac transplantation by correlating
ultiple clinical and genetic variables with LV
eformation. This exploration revealed an intrigu-
ng relationship of genetic expression profile as an
ndependent predictor of global LV strain at
-year after transplantation. On examining the in-
ividual components of the standard genetic test
mployed for the prediction of allograft rejection,
he correlation of LV deformation with gene ex-
ression score was seen to be primarily driven by
ene coding for semanophorin (SEMA 7A), a
embrane-tethered cell signaling molecule which
unctions in neural development and macrophage
Figure 1. Serial Changes in Longitudinal Strain After Cardiac
Transplantation
Color coded display shows the distribution of regional segments on
and amplitude of longitudinal strain on y-axis. The time scale repre
on the z-axis has been ﬂattened in the 3-dimensional volumetric di
focusing on spatial variations in longitudinal strains. A and B illustra
patient with improvement in longitudinal strains due to reduction i
(red) and improvement (blue) in longitudinal shortening strains at
months, whereas C and D illustrate a patient with lack of improvem
longitudinal strains. Note the reduction in shortening strains and in
stretch in the septum. The allograft recipients, such as in panels A
showed an uneventful course. Figure courtesy of Partho P. Sengupt
Mayo Clinic Arizona, Scottsdale, Arizona.x-axis
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1088nd T-cell activation pathways. This relationship
arallels recent reports where semanophorins have
een suggested to modulate transmural mechanics
5). Semanophorin has also been implicated in
einervation of the allograft, which is known to
nfluence myocardial performance after transplan-
ation. The uncharted exploration in the Eleid et
l. (2) study thus seems to fit nicely with some
bservations from other studies; indeed more of
uch collateral evidence may close the loop of
ossibilities. One could argue that there is suffi-
ient biological plausibility about the data and
urther research into this line of thinking seems
ustified. In addition to demonstrating the validity
f this unexpected finding, this study (2) also sup-
orts the important and often forgotten notion that
uccess in science is not only to discover new things,
ut also to better understand old observations in
ew ways.Ballester-Rodes, MD, and Ignasi Carrio, MD, Barcelona, Spain.5E F E R E N C E S
. Benjamini Y, Hochberg Y. Controlling
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Natural history of left ventricular me-
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al. Evaluation of biopsy classification
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Am J Physiol Heart Circ Physiol 2010;Figure 2. Serial Changes in the Indium-111-Labeled Antimyosin Antibody
Uptake After Transplantation
Antimyosin antibody uptake represents the presence of myocardial necrosis,
and a semi-quantitative extent of myocardial damage is assessed by calcula-
tion of heart-to-lung (H/L) ratio of the radiotracer uptake. The tracer uptake
is invariably seen after the transplantation which resolves gradually thereaf-
ter and parallels the rate of development of tolerance. The antimyosin stud-
ies from 2 allograft recipients (top and bottom) are presented at 1 (left)
and 3 (right) months after the transplantation. Panels A and B represent
resolving antimyosin antibody uptake that predicted an uneventful course.
C and D represent persistent antibody uptake; the post-transplantation
course was riddled with numerous complications. Figure courtesy of Manuel298:H1633–6.
